HIGH-ALTITUDE PULMONARY EDEMA: Current Concepts
Tóm tắt
▪ Abstract High-altitude pulmonary edema (HAPE) occurs in unacclimatized individuals who are rapidly exposed to altitudes in excess of 2450 m. It is commonly seen in climbers and skiers who ascend to high altitude without previous acclimatization. Initial symptoms of dyspnea, cough, weakness, and chest tightness appear, usually within 1–3 days after arrival. Common physical signs are tachypnea, tachycardia, rales, and cyanosis. Descent to a lower altitude, nifedipine, and oxygen administration result in rapid clinical improvement. Physiologic studies during the acute stage have revealed a normal pulmonary artery wedge pressure, marked elevation of pulmonary artery pressure, severe arterial unsaturation, and usually a low cardiac output. Pulmonary arteriolar (precapillary) resistance is elevated. A working hypothesis of the etiology of HAPE suggests that hypoxic pulmonary vasoconstriction is extensive but not uniform. The result is overperfusion of the remaining patent vessels with transmission of the high pulmonary artery pressure to capillaries. Dilatation of the capillaries and high flow results in capillary injury, with leakage of protein and red cells into the alveoli and airways. HAPE represents one of the few varieties of pulmonary edema where left ventricular filling pressure is normal.
Từ khóa
Tài liệu tham khảo
Ravenhill T, 1913, J. Trop. Med. Hyg., 20, 313
Crane H, 1927, Anal. Fac. Med., 2, 306
Bardales A, 1957, Rev. Peruana Cardiol., 6, 115
Vega B, 1956, JAMA, 160, 698
Hultgren H, 1960, Bull., 18, 76
Hultgren H, 1995, West. J. Med.
Hultgren H. 1978.High altitude pulmonary edema.InWater and Solute Exchange,ed. N Staub, pp. 437–64. New York: Marcel Dekker
Vock P, Fischer H, Bärtsch P. 1993.Radiomorphology of high altitude pulmonary edema: new views.InHypoxia and Molecular Medicine,ed. J Sutton, G Coates, C Houston, pp. 259–64. Burlington, VT: Queen City Printers
Hackett P, Oelz O. 1992.The Lake Louise Consensus of the definition and quantification of altitude illness.InHypoxia and Mountain Medicine,ed. J Sutton, G Coates, C Houston, pp. 327–30. Burlington, VT: Queen City Printers
Bärtsch P, Muller A, Hofstetter D, et al. 1993. AMS and HAPE scoring in the Alps. See Ref.16, pp. 265–71
Hultgren H. 1982. Pulmonary hypertension and pulmonary edema. InOxygen Transport to Human Tissues,ed. J Loeppky, M Riedesel. New York: Elsevier Biomedical
Hochstrasser J, 1986, Schweiz. Med. Wochenschr., 116, 866
Lobenhoffer H, Zink R, Brendel W. 1982. High altitude pulmonary edema: analysis of 166 cases. InHigh Altitude Physiology and Medicine,ed. W Brendel, R Kink. New York: Springer Verlag
Sophocles A, 1986, West. J. Med., 144, 569
Lopez C. 1971.Edema agudo pulmónar de altura in nimos.Doctoral thesis. Univ. Pervana Cayetano Heridia, Lima, Peru. 45 pp.
Antezana G, Leguia G, Guzman A, et al. 1982. Hemodynamic study of high altitude pulmonary edema (12,200 ft). See Ref.22, pp. 232–41
Fukushima M, 1980, Jpn. J. Thorac. Dis., 18, 753
Arias-Stella J, 1963, Arch. Pathol., 76, 147
Nayak N, 1964, Am. J. Pathol., 45, 381
Hyman A, 1961, J. Appl. Physiol., 217, 1177
Levinson R, 1986, Am. Rev. Respir. Dis., 139, 1291
King S, Greenlee R. 1990. Successful use of the Gamow hyperbaric bag in the treatment of altitude illness at Mount Everest. See Ref.61. pp. 193–202
Hackett P, Greene E, Roach P, et al. 1990.Nifedipine and hydralazine for treatment of high altitude pulmonary edema.InHypoxia: The Adaptations,ed. J Sutton, G Coates, J Remmers, p. 219. Philadelphia: B.C. Decker (Abstr.)
Gray G, 1971, Aero. Med., 42, 81